Hemodynamic responses to administration of metaproterenol and deslanoside were studied in 5 and 3 patients with aortic regurgitation, respectively. Metaproterenol pro duced an increase in forward stroke volume and aortic flow and a reduction in aortic regurgitant flow. In pure aortic regurgitation, these effects were related to a decreased left ventricular work. Deslanoside uniformly increased stroke volume, forward and regurgitant flows. Left ventricular work also increased after deslanoside administration. Calculated regurgitant valve orifice was changeable in association with alteration of inotropy and heart rate following administration of these drugs. The change of regurgitant flow was positively correlated with the change of regurgitant orifice area (r=0.988) and diastolic time (r=0.696). There was no close correlation between the regurgitant flow and systemic vascular resistance or diastolic pressure gradient from the aorta to left ventricle. It was concluded that when the hemodynamics in aortic insufficiency were altered by drug administration, the size of regurgitant orifice area and the duration of diastole were the important determinant of aortic regurgitation. aortic regurgitation; metaproterenol; dye dilution curve; aortic valve orifice; deslanoside The magnitude of aortic regurgitation depends principally upon the size of the regurgitant valve area, the diastolic pressure gradient across the orifice, and the duration of diastole. Variations in heart rate and inotropic state of cardiac muscle would be expected to alter the magnitude of regurgitation by changing the latter two parameters. Metaproterenol has a similar effect to isoproterenol as a beta-adrenergic stimulating agent, which exerts both positive chronotropic and inotropic effects on cardiac dynamics. Cardiac glycoside (deslanoside) also changes heart rate and inotropy of cardiac muscle. As described in the previous paper (Miyazawa et al. 1972) , it is now possible to measure the magnitude of aortic forward and regurgitant flows in man. The present study was undertaken to determine the effects of these two drugs on aortic regurgitation and the other hemodynamics in pateints with aortic incompetence.
with slight degree of stenosis underwent the study. The presence of aortic stenosis was indicated by peak systolic pressure gradient across the aortic valve more than 20mmHg. Five patients were male and three were female, and the average age was 35, ranging from 13 to 59 years. Cardiac catheterization was performed in the postabsorptive state.
Aortic forward and regurgitant flows were calculated from the dye concentration plateaus of dilution curves recorded simultaneously from the left ventricle and femoral artery following continuous injection of dye into the aortic root, as described in the pre vious report (Miyazawa et al. 1972 ). Intracardiac and systemic arterial pressures were measured by Statham P23 Db strain gauge and recorded with a Sanborn twin viso cardiette.
In 5 patients, 1.1mg of metaproterenol (Alotec?) dissolved with 20ml of distilled water were intravenously injected over a period of 5 minutes. After a period of 10 minutes to allow for hemodynamic stabilization, the measurements were repeated. Three patients received 0.8mg of deslanoside (Cedilanid?) intravenously by slow injection. Approximate ly 30 minutes after deslanoside injection, the measurements were made repeatedly. Stroke volume was obtained by dividing forward aortic flow by heart rate. Systemic vascular resistance was calculated as the ratio of mean systemic pressure to total aortic flow in the usual manner. Diastolic time per beat was calculated from successive 5 aortic pressure pulses as an interval between the diastolic notch and the onset of the next systolic upstroke. Systolic time per beat was estimated from the onset of the systolic upstroke to diastolic notch. Diastolic and systolic times per minute were calculated by multiplying the values per beat by heart rate. Left ventricular work was obtained from the formula of Ross and Braunwald (1964) , and aortic regurgitant orifice area was calculated from the formula of Gorlin et al. (1955) . Mean diastolic pressure gradient between aortic and left ventricular pressures was determined by planimetry using the simultaneously recorded pressure curves.
RESULTS
Hemodynamic data before and after administration of metaproterenol and deslanoside are shown in Table 1 . Following injection of metaproterenol, heart After deslanoside injection, heart rate was slightly decreased in all 3 cases, the average decrease being 5 beats/min (3-10 beats/min).
The forward aortic flow, stroke volume, and regurgitant flow uniformely increased, the average incre ment being 3.63 liter/min (1.21-6.25 liter/min), 39.4ml/stroke (27.0-60.0ml/stroke), and 2.32 liter/min (0.36-5.94 liter/min), respectively. Along with these changes in the blood flow through the aortic valve, the regurgitant fraction increased in I by 13.9% and decreased slightly in 2 by 0.6 and 4.6%. Systemic pressure was changed inconstantly. Diastolic time per minute increased by 1.5 sec on the average (0.6-3.0 sec). The calculated regurgitant valve area increased in all by 0.21cm2 on the average (0.01-0.56cm2). Reflecting the increased total aortic flow, the systemic vascular resistance reduced in all cases, the average decrease being 299 dyne -sec • cm-5 (116-519 dyne .sec.cm-5). Left ventircular work markedly increased by 5766g.m/ min on the average (1,182-11,055g .m/min), as the total aortic flow increased. The left ventricular end-diastolic pressure during the control period was normal in 2, and markedly elevated in 1 case. Following deslanoside injection, it was essentially unchanged in the first 2 cases and decreased in the last one.
DISCUSSION
In the presence of aortic regurgitation, the left ventricle usually compensates for increased end-diastolic volume due to regurgitation by increasing the total stroke volume. It has been reported that an increased heart rate reduces the duration of diastole and may diminish the aortic regurgitant volume (Gorlin et al. 1955 ; Warner and Toronto 1961; Malooly et al. 1963; Brawley and Morrow 1967) . If the heart rate of normal subject is increased by atrial pacing, the cardiac output remains constant over a fairly wide range of heart rates, because of progres sive decrease in stroke volume (Warner and Toronto 1960; Ross et al. 1965 ). Brawley and Morrow (1967) reported that in 6 patients with aortic regurgitation no significant change in either total forward or regurgitant flow per minute was found when heart rate was increased by atrial pacing.
When heart rate is changed by administration of metaproterenol or deslano side, the hemodynamic responses are expected to be quite different from those induced by aerial pacing. In these circumstances positive inotropic effect is pro bably a major determinant of the cardiac output response, so that the forward and total stroke volumes increase and consequently the forward and total aortic flows increase.
After receiving metaproterenol, the forward stroke volume and aortic flow increased in all 5 patients, while the regurgitant flow decreased in 4 of 5 patients in association with the increase in heart rate and the decrease in diastolic time. In 3 patients with pure aortic regurgitation, there was an associated decrease in left ventricular work. Although the aortic pressure was not necessarily reduced , the calculated systemic vascular resistance fell markedly in every case , due probably to the vasodilating properties of this drug . All of these would be advantageous to cardiac performance in aortic regurgitation. It is therefore considered that metaproterenol may be of use in the treatment of patients with aortic regurgitation. Elliott and Gorlin (1966) reported that the administration of isoproterenol gave some good results to patients with heart failure due to aortic insufficiency. It has been demonstrated that cardiac glycosides do not increase or decrease the cardiac output in normal subjects (Williams et al. 1958; Weissler et al. 1964) or patients without congenstive heart failure (Dresdale et al. 1959; Sonnenblick et al. 1964 ) despite increasing myocardial contractile force. In the present study, 3 patients with pure aortic regurgitation (although 2 of 3 were in the compensated state as judged by normal left ventricular end-diastolic pressure) showed an increase in forward and total stroke volumes and aortic flows after deslanoside administration.
Regurgitant flow increased concomitantly as the diastolic time increased. Marked increase in left ventricular work was observed in. connection with augmental total aortic flow. These findings indicate that the administration of deslanoside is not necessarily favorable to the hemodynamics in this disease. Kloster et al. (1967) reported that both forward aortic flow and left ventricular enddiastolic volume changed in the same direction after receiving ouabain and transla tion of its positive isotropic effect into improved cardiac performance was not apparent.
In this study, diastolic time was variably changed with metaproterenol, while increased uniformly with deslanoside. There was a good correlation between the changes of regurgitant flow and diastolic time (r=0.696) as shown in Fig. 1 . On the other hand, the alteration of regurgitant flow showed a poor correlation with the change of systemic vascular resistance (r=-0.01) or diastolic pressure gradient from the aorta to left ventricle (r=0.169). These results mean that when the hemodynamics in aortic regurgitation are changed by drug administration, the duration of diastole play an important role in determining the magnitude of regurgitation.
As presented above, regurgitant aortic valve area was changed following injection of these drugs. This phenomenon depends partly on the change in heart rate. Brawley and Morrow (1967) and Judge et al. (1971) indicated that when the heart rate was changed by electrical stimulation, moderate but no directionally consistent changes in the regurgitant valve area were observed with increasing heart rate. In our study, the change of diastolic valve area showed a negative correlation with heart rate (r=-0.474), suggesting that bradycardia accompanied by the increase in diastolic time have no beneficial effect on aortic regurgitation. As shown in Fig. 2 , the correlation between the changes of regurgitant flow and diastolic valve area was excellent (r=0.988) and the size of aortic orifice was the major determinant of regurgitant flow. Judge et al. (1971) described that the regurgitant orifice would change throughout the diastolic period in response to continuously changing pressure gradients and flows. It would be possible that in the presence of aortic regurgitation the size and shape of the valve orifice in diastole are changeable clue to the magnitude of regurgitant flow rate and the state of eddy on the upper surface of the valve. It is suggested from the present study that the change of regurgitant flow after receiving these drugs may result from the change of regurgitant aortic valve area.
